A SURGEON from Oxford who led a pioneering heart operation in Greece has demanded to be allowed to do it on the NHS.
Prof Stephen Westaby, who works at the John Radcliffe Hospital, spoke out after leading a surgical team in Greece who used a combination of an artificial heart and stem cells to save the life of a dying man.
‘I am very frustrated that all the work that I have done back home in the UK has to be translated into patient care in other countries’
It is thought to be the the first time the combination has been
Image via Wikipedia
Stem cells found in the amniotic liquid represent new hopes to treat diseases. For the 13th World Congress on Human Reproduction, which is taking place in Venice, Biocell and Toma, two companies based in the Lombardy region active in the field of prenatal diagnosis and biotechnology, today are presenting the results of research conducted by their scientific staff entitled “Characterization and cryoconservation of mesenchymal stem cells from the amniotic liquid”.
“Every day the amniotic liquid reveals its potential as a source of mesenchymal stem cells, creating increasing interest in the field of regenerative medicine,” said Professor Simoni,
After much hope and controversy, for the first time stem cells have proven to have the ability to cure blindness.
The news comes from a study on age-related macular degeneration (AMD) of the retina, the most common cause of blindness in individuals over the age of 50.
The Sunday Times reports that the treatment was developed by a group of British researchers, who say that in the next six to seven years the treatment will become a routine operation, which will not last more than an hour.
The treatment involves the replacement of a layer of degenerated cells with new cells created
Reviewing the technology, business models, intellectual property, regulatory concerns, transplantation and immune rejection.
Transplantation of hematopoietic stem cells has been widely used as an approved treatment of leukemia, lymphoma and certain autoimmune conditions for the past fifty years. Other adult stem cells have demonstrated safety and efficacy in pre-clinical research and clinical trials. Mesenchymal stem cell transplants have been most widely studied in animals, especially horses & dogs, and humans. Many of these studies have focused on skeletal-muscular effects.
There is significant support for safety and efficacy in osteoarthritis, including cartilage regeneration, pain and inflammation reduction as well as recovery of function using intra-articular MSC injections. There are fewer studies of neural stem